Active Ingredient History

  • Now
Darifenacin is a selective muscarinic receptor M3 antagonist which was approved by FDA for the treatment of overactive bladder.   NCATS

  • SMILES: NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5
  • Mol. Mass: 426.56
  • ALogP: 3.96
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$2.1044 - $12.5103
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

darifenacin | darifenacina | darifenacine | darifénacine | darifenacin hydrobromide | darifenacin hydrochloride | darifenacinum | darifenicin | emselex | enablex | oxybutynin darifenacin | (s)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide | uk-88525 | uk-88525-04


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue